Difference between revisions of "Talk:Cardiopulmonary mortality attributable to PM2.5 in Helsinki metropolitan area"
(→scope) |
Eva Kunseler (talk | contribs) (→formula) |
||
| Line 5: | Line 5: | ||
|Outcome= Under discussion (to be changed when a conclusion is found) | |Outcome= Under discussion (to be changed when a conclusion is found) | ||
|Argumentation = {{attack|#: |No reference provided, illegible, unsure if it is correct and appropriate and there are other alternative models |--[[User:Anazelle|Anazelle]] 15:24, 18 February 2009 (EET)}} | |Argumentation = {{attack|#: |No reference provided, illegible, unsure if it is correct and appropriate and there are other alternative models |--[[User:Anazelle|Anazelle]] 15:24, 18 February 2009 (EET)}} | ||
| − | + | {{comment|#: ||--[[User:Eva Kunseler|Eva Kunseler]] 15:39, 18 February 2009 (EET)}} | |
}} | }} | ||
Revision as of 13:39, 18 February 2009
Contents
formula
| Statements:
Resolution: Resolution not yet found. (A stable resolution, when found, should be updated to the main page.) |
| Argumentation:
⇤#: : No reference provided, illegible, unsure if it is correct and appropriate and there are other alternative models --Anazelle 15:24, 18 February 2009 (EET) --#: : --Eva Kunseler 15:39, 18 February 2009 (EET) |
scope
| Statements:
Resolution: Resolution not yet found. (A stable resolution, when found, should be updated to the main page.) |
| Argumentation:
⇤#: : the scope includes PM2.5 exposure boundaries, which is irrelevant for this variable. --Anazelle 15:26, 18 February 2009 (EET) |
Clarification of scope
PM2,5 exposure
Should PM2,5 exposure be defined in the variable ?
PM2,5 exposure-response function
We are depending on how the ERF is defined in order to find the connecting baseline data on cardiopulmonary mortality.
- What health endpoints are covered with ERFs?
- What is the ICD code of the health endpoints
Population of Helsinki metropolitan area
We would need to know how the population of the Helsinki metropolitan area is defined in order to specify the baseline data on cardiopulmonary mortality for certain groups. For example, is there a distinction in subgroups such as age groups, gender, sensititivity etc.?
